Campbell Bradley L sold FOLD
April 27, 2026 · Form 4 insider transaction
Campbell Bradley L sold 1,008,680 shares of Amicus Therapeutics, Inc. at $14.50 per share, a transaction worth $14.63M. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,008,680
Price
$14.50
Total value
$14.63M
InsiderCampbell Bradley L
RoleOfficer, Director
SecurityCommon Stock
Transaction codeD: Disposition to the issuer
Transaction dateApril 27, 2026
Filing dateApril 27, 2026
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reported securities were disposed of in connection with consummation of the acquisition of the Issuer by BioMarin Pharmaceutical Inc. (the "Merger"), which included 689,467 shares of Common Stock and 319,213 restricted stock units (which vested in full in connection with consummation of the Merger).